Targeted defa5 antibody and assay methods for diagnosing and treating inflammatory bowel disease

作者: Amos Sakwe , Amosy M'koma

DOI:

关键词: Ulcerative colitisImmunologyMedicineInflammatory bowel diseaseAntibodyDisease

摘要: A targeted DEFA5 antibody is disclosed herein. The has a high degree of specificity with protein, particularly peptide sequences the P, B, and/or M binding sites protein. may be incorporated into an assay for diagnosing and treating ulcerative colitis Crohns disease in subject suffering from inflammatory bowel disease. provided kit. used method measuring level or expression sample collected subject, determining, based on expression, whether treatment determination

参考文章(4)
Dominique Rolland, Corinne Beaulieu, Jean-Philippe Charrier, Sandrine Busseret, Geneviève Choquet-Kastylevsky, Yasemin Ataman-Önal, Prodefensin-a6 assay method for the in vitro diagnosis of colorectal cancer ,(2010)
Jack Satsangi, Charles Lees, Alexander R. Abbas, Colin L. Noble, Lauri Diehl, Hilary Clark, Gene expression markers for inflammatory bowel disease ,(2008)
Amanda D. Williams, Olga Y. Korolkova, Amos M. Sakwe, Timothy M. Geiger, Samuel D. James, Roberta L. Muldoon, Alan J. Herline, J. Shawn Goodwin, Michael G. Izban, Mary K. Washington, Duane T. Smoot, Billy R. Ballard, Maria Gazouli, Amosy E. M'Koma, Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLOS ONE. ,vol. 12, ,(2017) , 10.1371/JOURNAL.PONE.0179710
Vandussen Kelli, Liu Ta-Chiang, Stappenbeck Thaddeus, METHODS FOR PROGNOSING CROHN'S DISEASE COMPRISING HUMAN DEFENSIN 5 (HD5) ,(2017)